Literature DB >> 7882563

Autoimmunity in ulcerative colitis: tropomyosin is not the major antigenic determinant of the Das monoclonal antibody, 7E12H12.

M I Hamilton1, N J Bradley, S K Srai, C Thrasivoulou, R E Pounder, A J Wakefield.   

Abstract

Ulcerative colitis (UC) has a proposed autoimmune pathogenesis. A 40-kD antigen (P40) has been isolated from UC colon, bound to immunoglobulin. Tropomyosin has been reported as the target antigen of a MoAb (7E12H12) raised against P40. We set out to investigate whether tropomyosin is the major antigenic determinant for 7E12H12. Formalin-fixed, paraffin-processed and cryostat sections of fresh frozen colon from patients with UC, Crohn's disease and normals, were immunostained with 7E12H12 and commercial anti-tropomyosin antibodies. In addition, the immunoreactivity of 7E12H12 with cytoskeletal components was examined on human endothelial cells (HUVEC) using anti-tropomyosin as a positive control. Con-focal microscopy was used to determine the subcellular localization of signal. An extract of total colonic protein from UC colon was prepared. Using a combination of Western and immunoblotting (dot-blots), the immunoreactivities of both tropomyosin (porcine and chicken) and colon protein extract with either 7E12H12 or commercial anti-tropomyosin were examined. Immunocytochemically, 7E12H12 localized to the apical and basolateral regions of plasma membrane, and to the supranuclear cytoplasm in colonic epithelium. Using anti-tropomyosin antibody it was not possible to identify the cytoskeleton in colonic epithelium. Cytoskeletal components were identifiable in HUVEC cultures with anti-tropomyosin antibody but not with 7E12H12. P40 antigen was identified in the colon protein extract by immunoblotting with 7E12H12. There was clear immunoreactivity between anti-tropomyosin antibody and both chicken and porcine tropomyosin, and the colon protein extract. 7E12H12 did not bind to either chicken or porcine tropomyosin in appropriately controlled systems. We conclude that the pattern of immunostaining with 7E12H12 is not cytoskeletal, and there is no reactivity in immunoblots, between tropomyosin and 7E12H12. Tropomyosin is not the major target antigen of this antibody in ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7882563      PMCID: PMC1534197          DOI: 10.1111/j.1365-2249.1995.tb05565.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody.

Authors:  K M Das; M Vecchi; S Sakamaki
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

2.  Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis.

Authors:  T S Halstensen; K M Das; P Brandtzaeg
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

3.  Circulating antibodies against human colonic extract enriched with a 40 kDa protein in patients with ulcerative colitis.

Authors:  F Takahasi; H S Shah; L S Wise; K M Das
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

4.  Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis.

Authors:  F Takahashi; K M Das
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

5.  Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment.

Authors:  M Oudkerk Pool; P M Ellerbroek; B U Ridwan; R Goldschmeding; B M von Blomberg; A S Peña; K M Dolman; H Bril; W Dekker; J J Nauta
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

6.  Autoimmunity to cytoskeletal protein tropomyosin. A clue to the pathogenetic mechanism for ulcerative colitis.

Authors:  K M Das; A Dasgupta; A Mandal; X Geng
Journal:  J Immunol       Date:  1993-03-15       Impact factor: 5.422

7.  Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases.

Authors:  J F Colombel; D Reumaux; P Duthilleul; L H Noël; C Gower-Rousseau; J C Paris; A Cortot
Journal:  Gastroenterol Clin Biol       Date:  1992

Review 8.  Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders.

Authors:  C G Kallenberg; A H Mulder; J W Tervaert
Journal:  Am J Med       Date:  1992-12       Impact factor: 4.965

9.  The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody.

Authors:  K M Das; S Sakamaki; M Vecchi; B Diamond
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

10.  Localization of myosin, actin, and tropomyosin in rat intestinal epithelium: immunohistochemical studies at the light and electron microscope levels.

Authors:  D Drenckhahn; U Gröschel-Stewart
Journal:  J Cell Biol       Date:  1980-08       Impact factor: 10.539

View more
  4 in total

Review 1.  Autoantibodies in primary sclerosing cholangitis.

Authors:  Johannes-Roksund Hov; Kirsten-Muri Boberg; Tom-H Karlsen
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

2.  Detection of anti-colon antibodies in inflammatory bowel disease using human cultured colonic cells.

Authors:  J C Lee; A M Cevallos; A Naeem; J E Lennard-Jones; M J Farthing
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

Review 3.  Immunopathology of human inflammatory bowel disease.

Authors:  P Brandtzaeg; G Haraldsen; J Rugtveit
Journal:  Springer Semin Immunopathol       Date:  1997

4.  Externalization of tropomyosin isoform 5 in colon epithelial cells.

Authors:  K V Kesari; N Yoshizaki; X Geng; J J Lin; K M Das
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.